{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:38:54Z","timestamp":1789627134286,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,18]]},"DOI":"10.7759\/cureus.62629","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T20:39:17Z","timestamp":1718743157000},"source":"Crossref","is-referenced-by-count":1,"title":["Feeling a Little Blue After Ablation: Iatrogenic Atrial Septal Defect With Right-to-Left Shunt Following Atrial Fibrillation Ablation"],"prefix":"10.7759","author":[{"given":"Lindsey","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Arbogast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden","family":"Ivey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Frugoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Dukes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Atrial fibrillation: are there gender differences?","volume":"3","author":"Michelena HI","year":"2000","unstructured":"Michelena HI, Ezekowitz MD. Atrial fibrillation: are there gender differences?. J Gend Specif Med. 2000, 3:44-9.","journal-title":"J Gend Specif Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/157340312803760721","article-title":"Triggers and anatomical substrates in the genesis and perpetuation of atrial fibrillation","volume":"8","author":"S\u00e1nchez-Quintana D","year":"2012","unstructured":"S\u00e1nchez-Quintana D, L\u00f3pez-M\u00ednguez JR, Pizarro G, Murillo M, Cabrera JA. Triggers and anatomical substrates in the genesis and perpetuation of atrial fibrillation. Curr Cardiol Rev. 2012, 8:310-26. 10.2174\/157340312803760721","journal-title":"Curr Cardiol Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.019893","article-title":"Atrial fibrillation pathophysiology: implications for management","volume":"124","author":"Iwasaki YK","year":"2011","unstructured":"Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation. 2011, 124:2264-74. 10.1161\/CIRCULATIONAHA.111.019893","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the cabana randomized clinical trial","volume":"321","author":"Packer DL","year":"2019","unstructured":"Packer DL, Mark DB, Robb RA, et al.. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the cabana randomized clinical trial. JAMA. 2019, 321:1261-74. 10.1001\/jama.2019.0693","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021727","article-title":"Ablation of atrial fibrillation: patient selection, periprocedural anticoagulation, techniques, and preventive measures after ablation","volume":"134","author":"Link MS","year":"2016","unstructured":"Link MS, Ha\u00efssaguerre M, Natale A. Ablation of atrial fibrillation: patient selection, periprocedural anticoagulation, techniques, and preventive measures after ablation. Circulation. 2016, 134:339-52. 10.1161\/CIRCULATIONAHA.116.021727","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.113.000768","article-title":"Complications of catheter ablation of atrial fibrillation: a systematic review","volume":"6","author":"Gupta A","year":"2013","unstructured":"Gupta A, Perera T, Ganesan A, et al.. Complications of catheter ablation of atrial fibrillation: a systematic review. Circ Arrhythm Electrophysiol. 2013, 6:1082-8. 10.1161\/CIRCEP.113.000768","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-019-00598-9","article-title":"Prospective evaluation of iatrogenic atrial septal defect after cryoballoon or radiofrequency catheter ablation of atrial fibrillation-\"EVITA\" study","volume":"56","author":"Nagy Z","year":"2019","unstructured":"Nagy Z, Kis Z, G\u00e9czy T, et al.. Prospective evaluation of iatrogenic atrial septal defect after cryoballoon or radiofrequency catheter ablation of atrial fibrillation-\"EVITA\" study. J Interv Card Electrophysiol. 2019, 56:19-27. 10.1007\/s10840-019-00598-9","journal-title":"J Interv Card Electrophysiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni OM","year":"2005","unstructured":"Wazni OM, Marrouche NF, Martin DO, et al.. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005, 293:2634-40. 10.1001\/jama.293.21.2634","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.02.068","article-title":"Iatrogenic atrial septal defect following transseptal cardiac interventions","volume":"209","author":"Alkhouli M","year":"2016","unstructured":"Alkhouli M, Sarraf M, Zack CJ, Holmes DR, Rihal CS. Iatrogenic atrial septal defect following transseptal cardiac interventions. Int J Cardiol. 2016, 209:142-8. 10.1016\/j.ijcard.2016.02.068","journal-title":"Int J Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo CA","year":"2014","unstructured":"Morillo CA, Verma A, Connolly SJ, et al.. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014, 311:692-700. 10.1001\/jama.2014.467","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3791\/52811","article-title":"Reduction of iatrogenic atrial septal defects with an anterior and inferior transseptal puncture site when operating the cryoballoon ablation catheter","author":"Rich ME","year":"2015","unstructured":"Rich ME, Tseng A, Lim HW, Wang PJ, Su WW. Reduction of iatrogenic atrial septal defects with an anterior and inferior transseptal puncture site when operating the cryoballoon ablation catheter. J Vis Exp. 2015, e52811. 10.3791\/52811","journal-title":"J Vis Exp"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4022\/jafib.1226","article-title":"Very long-term results of atrial fibrillation ablation confirm that this therapy is really effective","volume":"8","author":"Tutuianu C","year":"2015","unstructured":"Tutuianu C, Szilagy J, Pap R, S\u00e1ghy L. Very long-term results of atrial fibrillation ablation confirm that this therapy is really effective. J Atr Fibrillation. 2015, 8:1226. 10.4022\/jafib.1226","journal-title":"J Atr Fibrillation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/pace.12663","article-title":"One year incidence of atrial septal defect after PV isolation: a comparison between conventional radiofrequency and cryoballoon ablation","volume":"38","author":"Mugnai G","year":"2015","unstructured":"Mugnai G, Sieira J, Ciconte G, et al.. One year incidence of atrial septal defect after PV isolation: a comparison between conventional radiofrequency and cryoballoon ablation. Pacing Clin Electrophysiol. 2015, 38:1049-57. 10.1111\/pace.12663","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.04.034","article-title":"Persistence of iatrogenic atrial septal defect after pulmonary vein isolation--an underestimated risk?","volume":"152","author":"Hammerstingl C","year":"2006","unstructured":"Hammerstingl C, Lickfett L, Jeong KM, et al.. Persistence of iatrogenic atrial septal defect after pulmonary vein isolation--an underestimated risk?. Am Heart J. 2006, 152:362.e1-5. 10.1016\/j.ahj.2006.04.034","journal-title":"Am Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.15420\/aer.2012.1.29","article-title":"Catheter ablation of atrial fibrillation - techniques and technology","volume":"1","author":"Katritsis G","year":"2012","unstructured":"Katritsis G, Calkins H. Catheter ablation of atrial fibrillation - techniques and technology. Arrhythm Electrophysiol Rev. 2012, 1:29-33. 10.15420\/aer.2012.1.29","journal-title":"Arrhythm Electrophysiol Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/180816-feeling-a-little-blue-after-ablation-iatrogenic-atrial-septal-defect-with-right-to-left-shunt-following-atrial-fibrillation-ablation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T20:39:20Z","timestamp":1718743160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/180816-feeling-a-little-blue-after-ablation-iatrogenic-atrial-septal-defect-with-right-to-left-shunt-following-atrial-fibrillation-ablation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.62629","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,18]]}}}